I like point 4 the most.

First 91 Last

Share
Profile

Follow
newt9905

121 Posts.

4

20/09/18

10:45

Post #: 35720582
Share

Originally posted by TerribleTadpole ↑

"I find this raising distasteful" – You too? So do I.

I emailed Brian and Tony, which provoked a reasonably forthright telephone conversation, which in turn provided a bit more perspective about why a CR and why do it this way. This is my understanding of Brian's comments:

1) Working capital was sufficient only through to early CY2019. And while there are potential revenue sources, nothing is guaranteed at this point. There isn't enough time to rely on being able to stitch up an income.

2) Liquidity was way too low against the market capitalisation of the company, which meant waiting longer to raise would put the risk profile outside the guidelines of potential future backers.

3) A placement is faster, cheaper and less risky than a rights issue. A rights issue has to be held open for several weeks. If the share price were to drop below the issue price during that time the issue could fail to raise the necessary funds, with repercussions for operations and subsequent capital raising activities. On the back of recent price action, retracement seemed a big risk.

4) The reference to "high-quality" investors relates to new investors with a similar strategy to Fidelity, who have solidly backed the company since taking up their first stake.

So I still don't like it... but given that the raising is done, was successful, was necessary, wasn't too dilutive, and if we succeed with Smartcough-C2 may be the last one we need... I can live with the decision.

Expand

I like point 4 the most.

RAP Price at posting: 23.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

RCE

Recce's R327 found effective against E.coli during clinical trial

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

There are more pages in this discussion • 16 more messages in this thread...

First 91 Last

Add RAP (ASX) to my watchlist

I like point 4 the most.

Top Stories

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Featured News